The macroeconomic impact of non-communicable diseases in China and India: Estimates, projections, and comparisons

被引：35

作者：

Bloom, David E. ^{[1
]}

Cafiero-Fonseca, Elizabeth T. ^{[7
]}

McGovern, Mark E. ^{[1
,2
]}

Prettner, Klaus ^{[3
]}

Stanciole, Anderson ^{[4
]}

Weiss, Jonathan ^{[5
,6
]}

Bakkila, Samuel ^{[7
]}

Rosenberg, Larry ^{[7
]}

机构：

[1] Harvard Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave,Bldg 1,12th Floor,Suite 1202, Boston, MA 02115 USA

[2] Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA

[3] Vienna Univ Technol, Inst Math Methods Econ, A-1040 Vienna, Austria

[4] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA

[5] London Sch Hyg & Trop Med, London WC1E 7HT, England

[6] UNICEF Supply Div, DK-2100 Copenhagen O, Denmark

[7] Harvard Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA

来源：

JOURNAL OF THE ECONOMICS OF AGEING | 2014年 / 4卷

关键词：

Health and economic development; Non-communicable disease; Economic growth; Cost benefit analysis;

D O I：

10.1016/j.jeoa.2014.08.003

中图分类号：

C921 [人口统计学];

学科分类号：

摘要：

This study provides estimates of the macroeconomic impact of non-communicable diseases (NCDs) in China and India for the period 2012-2030. Our estimates are derived using the World Health Organization's EPIC model of economic growth, which focuses on the negative effects of NCDs on labor supply and capital accumulation. We present results for the five main NCDs (cardiovascular disease, cancer, chronic respiratory disease, diabetes, and mental health). Our undiscounted estimates indicate that the cost of the five main NCDs will total USD 23.03 trillion for China and USD 4.58 trillion for India (in 2010 USD). For both countries, the most costly domain is cardiovascular disease. Our analyses also reveal that the costs are much larger in China than in India mainly because of China's higher and steeper income trajectory, and to a lesser extent its older population. Rough calculations also indicate that WHO's best buys for addressing the challenge of NCDs are highly cost-beneficial. (C) 2014 Elsevier B. V. All rights reserved.

引用

页码：100 / 111

页数：12

共 50 条

[31] Chronic non-communicable diseases
Iain Chapple
Nairn Wilson
British Dental Journal, 2014, 216 : 487 - 487
[32] Non-Communicable Diseases: A Compendium
Manik, Elya
Widiastuti, Melina Ayu
Rahmah, Widya
DEATH STUDIES, 2024,
[33] Non-Communicable Diseases: A challenge
Kumar, S.
Kaushik, A.
INDIAN JOURNAL OF COMMUNITY HEALTH, 2012, 24 (04) : 252 - 254
[34] Updates on communicable and non-communicable diseases in LMICs
Tumwine, James K.
AFRICAN HEALTH SCIENCES, 2016, 16 (01) : I - IV
[35] Non-communicable diseases in prisons
Arnold, Frank W.
LANCET, 2012, 379 (9830): : 1931 - 1933
[36] NON-COMMUNICABLE DISEASES IN THE PACIFIC
FINAU, S
MEDICAL JOURNAL OF AUSTRALIA, 1984, 140 (04) : 243 - 243
[37] The Non-Communicable Diseases Alliance
Jagait, Charanjit
EUROPEAN HEART JOURNAL, 2013, 34 (31) : 2422 - 2423
[38] When communicable and non-communicable diseases collide
Chaulk, C. Patrick
Baruch, Nancy G.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (07) : 749 - 749
[39] Integration of communicable and non-communicable diseases within the health system of India: A window of opportunity?
Bhattacharya, Sudip
Tripathi, Shailesh
Gupta, Pratima
Varshney, Saurabh
Vallabh, Vidisha
FRONTIERS IN PUBLIC HEALTH, 2023, 10
[40] Priorities in tackling non-communicable diseases in children and adolescents in China
Ni, Xin
Li, Zhe
Zhang, Xiao
Li, Xinping
Liu, Yingying
Bai, Guoliang
Yang, Zhuoyu
LANCET CHILD & ADOLESCENT HEALTH, 2023, 7 (04): : 228 - 230

← 1 2 3 4 5 →